ServiceNow stock slides near year-low levels as Wall Street sizes up AI push and next earnings

ServiceNow stock slides near year-low levels as Wall Street sizes up AI push and next earnings

New York, Jan 14, 2026, 12:49 EST — Regular session

  • ServiceNow shares dropped roughly 2.6% by midday, deepening their steep decline from earlier this year.
  • Evercore ISI stuck with its Outperform rating, noting steady demand and highlighting interest in “Now Assist” AI tools.
  • Investors are zeroing in on the Jan. 28 results, expecting updates on guidance and the acquisition pipeline.

ServiceNow shares dropped 2.6% to $134.64 on Wednesday, after hitting a low of $134.43 earlier in the session. The stock had closed at $138.19 on Tuesday.

This move is significant as the stock has been dropping alongside the wider software sector, with traders growing nervous ahead of earnings. Around this price point, even a slight shift in demand outlook can quickly move the tape.

ServiceNow is set to release its quarterly results in two weeks. The stock has turned into a key gauge of whether large firms continue investing in workflow software or hold back on projects once more.

Evercore ISI maintained its Outperform rating on ServiceNow, holding the price target at $225. The firm pointed to solid demand and growing interest in the company’s “Now Assist” product. They also emphasized “annual recurring revenue,” a subscription-based metric that annualizes contracted revenue, as a crucial measure for tracking ServiceNow’s AI efforts. Investing.com UK

ServiceNow offers enterprise software designed to streamline IT and business workflows through its cloud platform, increasingly promoting AI capabilities to boost automation.

Investors are absorbing ServiceNow’s $7.75 billion deal to acquire cybersecurity startup Armis, marking the company’s largest acquisition yet, expected to finalize in the latter half of 2026. “Our security stack, with the acquisition of Armis, is very well positioned,” CFO Gina Mastantuono told Reuters. Reuters

In a separate note this week, Omdia analyst Adam Holtby described the Armis deal as “a platform power play,” designed to boost ServiceNow’s influence across security, risk, and AI governance. Holtby cautioned that success will depend heavily on how seamlessly Armis is woven into ServiceNow’s data and workflow layers. Omdia

The near-term risk is clear: if management downplays renewals, signals deal slippage, or reports slow adoption of new AI add-ons, the stock could remain stuck near its lows. On top of that, heavy M&A rumors wouldn’t provide any relief.

Investors are now focused on the upcoming earnings and guidance, not the buzzwords. For ServiceNow, the key points are subscription growth, insights on AI attach rates, and clues about customer budgets as companies finalize their plans for 2026.

ServiceNow will report its fourth-quarter and full-year 2025 earnings after the market closes on Jan. 28. A conference call is scheduled for 2 p.m. Pacific.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Taiwan Semiconductor

NYSE: TSM 96 / 100
#2 BUY

AerCap

NYSE: AER 95 / 100
#3 BUY ON PULLBACK

Constellation Energy

NASDAQ: CEG 93 / 100
#4 BUY

Walt Disney

NYSE: DIS 90 / 100
#5 ACCUMULATE

American International Group

NYSE: AIG 87 / 100
View full portfolio
Editorial model selection. Not personalised advice.
India’s ₹3.25 lakh crore Rafale mega-buy heads to talks — Dassault, Thales and Safran shares in focus
Previous Story

India’s ₹3.25 lakh crore Rafale mega-buy heads to talks — Dassault, Thales and Safran shares in focus

Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle
Next Story

Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle